.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Deloitte
Mallinckrodt
Fish and Richardson
Covington
Johnson and Johnson
AstraZeneca
Novartis
Chinese Patent Office
Fuji

Generated: January 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 02016860

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-005Apr 2, 2012RXYesNo➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-002May 9, 2007RXYesNo➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-003May 9, 2007RXYesNo➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-006Apr 2, 2012RXYesNo➤ Subscribe➤ SubscribeYA METHOD FOR THE TREATMENT OF A PATIENT SUFFERING FROM A DISEASE TREATABLE WITH ROTIGOTINE, COMPRISING APPLYING THE CLAIMED TRANSDERMAL DELIVERY SYSTEM (TDS) TO THE SKIN OF THE PATIENT
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-004Apr 2, 2012RXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF SIGNS AND SYMPTOMS OF PARKINSON'S DISEASE BY APPLICATION OF CLAIMED TRANSDERMAL SYSTEM
Ucb IncNEUPROrotigotineFILM, EXTENDED RELEASE;TRANSDERMAL021829-001May 9, 2007RXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF RESTLESS LEGS SYNDROME BY APPLICATION OF CLAIMED TRANSDERMAL DELIVERY SYSTEM
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist